(Allergan plc)

	AGN latest price $150.9123 (1.16%) ($147.5144 - $150.9614) on Fri. May. 11, 2018.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.07% (three month average)
RSI	41
Latest Price	$150.9123(1.16%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.6% a day on average for past five trading days.
Weekly Trend	AGN declines -3.3% a week on average for past two weeks.
Market Behavior	Normal for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(50%)    XLV(48%)    XBI(46%)    SPY(45%)    ARKG(44%)
Factors Impacting AGN price	AGN will decline at least -1.035% in a week (0% probabilities).   VIXM(-28%)    TLT(-21%)    UUP(-19%)    DIA(-9%)    GDXJ(-6%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.035% (StdDev 2.07%)
Hourly BBV	0 ()
Intraday Trend	1.2%

1 - 5 Day Possible Target	$139.54(-7.54%)
Resistance Level	$152.34
5 Day Moving Average	$145.88(3.45%)
10 Day Moving Average	$147(2.66%)
20 Day Moving Average	$152.34(-0.94%)
To recent high	-9%
To recent low	6.9%
Market Cap	$49.756b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed